Los Angeles Cancer Network — Anaheim, California

Los Angeles Cancer Network is a clinical research site located in Anaheim, California, United States 92801.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Los Angeles Cancer Network has participated in 7 clinical trials with 7 currently active.

Therapeutic areas: Metastatic Castrate Resistant Prostate Cancer (mCRPC), Gastroesophageal-junction Cancer, Monoclonal Antibody.

Sponsors: Pfizer, Shanghai Henlius Biotech, Amgen.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Los Angeles Cancer Network?

Los Angeles Cancer Network has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Los Angeles Cancer Network conducted?

Los Angeles Cancer Network has 7 clinical trials on record, with 7 currently active. Their work covers Metastatic Castrate Resistant Prostate Cancer (mCRPC), Gastroesophageal-junction Cancer, Monoclonal Antibody.

Is Los Angeles Cancer Network accredited by Crixeo Health?

Yes — Los Angeles Cancer Network holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Los Angeles Cancer Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.